Compound ID | 70
HY-133
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Natural product; Direct acting; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall degradation |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Institute of Medical Microbiology - University Hospital Münster, Münster,Germany |
| Year first mentioned: | 2011 |
| Highest developmental phase: | Phase 1 |
| Development status: | Active |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.